Analyst firms · Jefferies · VTGN
Jefferies VTGN price target and rating history
Vistagen Therapeutics Inc. (VTGN) · Health Care
Jefferies rates Vistagen Therapeutics Inc. (VTGN) Hold with a $0.90 price target, as of its latest action on Dec 17, 2025. It has published 3 rating actions on VTGN since July 2022, including 1 upgrade and 2 downgrades.
- Current rating
- Hold
- Price target
- $0.90
- Median target, all firms
- Too few
- Actions on VTGN
- 3
Jefferies price target on VTGN
Every Jefferies rating on VTGN
- Dec 17, 2025
- Dec 7, 2023
- Jul 22, 2022
How other firms rate VTGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Hold | $0.90 | Dec 17, 2025 |
| Maxim Group | Hold | Dec 17, 2025 | |
| William Blair | Mkt Perform | Dec 17, 2025 | |
| Stifel | Hold | $1 | Dec 17, 2025 |
Questions about Jefferies and VTGN
- What is Jefferies's price target for VTGN?
- Jefferies's latest stated price target for Vistagen Therapeutics Inc. (VTGN) is $0.90, from its action on Dec 17, 2025.
- What is Jefferies's rating on VTGN?
- Jefferies rates VTGN Hold, a neutral rating, as of Dec 17, 2025.
- When did Jefferies last change its view on VTGN?
- On Dec 17, 2025, Jefferies downgrades to Hold from Buy, price target $0.90.
All Jefferies ratingsVTGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.